HIV Envelope Protein gp160
"HIV Envelope Protein gp160" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kDa and contains numerous glycosylation sites. It serves as a precursor for both the HIV ENVELOPE PROTEIN GP120 and the HIV ENVELOPE PROTEIN GP41.
| Descriptor ID |
D019302
|
| MeSH Number(s) |
D12.776.964.775.325.164.374 D12.776.964.775.562.500.750 D12.776.964.970.880.325.164.374
|
| Concept/Terms |
HIV Envelope Protein gp160- HIV Envelope Protein gp160
- Envelope Glycoprotein gp160, HIV
- HTLV-III gp160
- HTLV III gp160
- gp160, HTLV-III
- gp160(HIV)
- HIV Envelope Glycoprotein gp160
- env Protein gp160, HIV
- gp160 Envelope Glycoprotein, HIV
|
Below are MeSH descriptors whose meaning is more general than "HIV Envelope Protein gp160".
Below are MeSH descriptors whose meaning is more specific than "HIV Envelope Protein gp160".
This graph shows the total number of publications written about "HIV Envelope Protein gp160" by people in this website by year, and whether "HIV Envelope Protein gp160" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV Envelope Protein gp160" by people in Profiles.
-
McManus M, Karalius B, Patel K, Persaud D, Luzuriaga K. Quantitative HIV-1-specific antibodies as predictors of peripheral blood cell-associated HIV-1 DNA concentrations. AIDS. 2020 07 01; 34(8):1117-1126.
-
Dejucq N, Simmons G, Clapham PR. T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism. J Gen Virol. 2000 Dec; 81(Pt 12):2899-2904.
-
Beyrer C, Artenstein AW, Rugpao S, Stephens H, VanCott TC, Robb ML, Rinkaew M, Birx DL, Khamboonruang C, Zimmerman PA, Nelson KE, Natpratan C. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis. 1999 Jan; 179(1):59-67.
-
Artenstein AW, VanCott TC, Sitz KV, Robb ML, Wagner KF, Veit SC, Rogers AF, Garner RP, Byron JW, Burnett PR, Birx DL. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J Infect Dis. 1997 Feb; 175(2):265-71.
-
Montefiori DC, Graham BS, Zhou J, Zhou J, Bucco RA, Schwartz DH, Cavacini LA, Posner MR. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network. J Clin Invest. 1993 Aug; 92(2):840-7.
-
Oh SK, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J, Kornfeld H. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr (1988). 1992; 5(3):251-6.
-
Finberg RW, Wahl SM, Allen JB, Soman G, Strom TB, Murphy JR, Nichols JC. Selective elimination of HIV-1-infected cells with an interleukin-2 receptor-specific cytotoxin. Science. 1991 Jun 21; 252(5013):1703-5.
-
Hosmalin A, Nara PL, Zweig M, Lerche NW, Cease KB, Gard EA, Markham PD, Putney SD, Daniel MD, Desrosiers RC, et al. Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates. J Immunol. 1991 Mar 01; 146(5):1667-73.